Get the Stockscreener App
1.13
3.42%
-0.04
After Hours:
1.12
-0.010
-0.88%
FibroGen Inc Stock (FGEN) Forecast
The FibroGen Inc (FGEN) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $6.838, representing a +505.14% increase from the current price of $1.13. The highest analyst price target is $11.73, and the lowest is $1.9464.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month FGEN Price Target
Average 9.4262
(+734.18% Upside)
Is FibroGen Inc (FGEN) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 36.41 | Neutral |
| STOCH(9,6) | 49.23 | Neutral |
| STOCHRSI(14) | 87.02 | Sell |
| MACD(12,26) | -0.2023 | Buy |
| ADX(14) | 38.49 | Sell |
| William %R | -51.18 | Neutral |
| CCI(14) | 14.70 | Neutral |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.0914
Buy
|
1.1452
Sell
|
| MA20 |
1.2412
Sell
|
1.2922
Sell
|
| MA50 |
1.733
Sell
|
1.5197
Sell
|
| MA100 |
1.4813
Sell
|
1.7067
Sell
|
| MA200 |
1.2234
Sell
|
4.1143
Sell
|
Buy: 1
Sell: 9
Neutral: 0
Summary: Sell
According to our latest analysis, FGEN could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 11 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on FGEN, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 36.41 indicates that FGEN is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 49.23 indicates that FGEN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 87.02 indicates that FGEN is oversold. This suggests that FGEN price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 38.49 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 14.7 indicates that FGEN is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term FGEN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about FibroGen Inc financial reports and earnings history, FibroGen Inc (FGEN) stock could reach $32.28 by 2030, $6.0268 by 2040 and $65.93 by 2050. See the projected annual prices until 2050 of the FibroGen Inc stock below:
- FibroGen Inc (FGEN) is expected to reach an average price of $8.1688 in 2035, with a high prediction of $8.999 and a low estimate of $8.1838. This indicates an $622.90% rise from the last recorded price of $1.13.
- FibroGen Inc (FGEN) stock is projected to chart a bullish course in 2040, with an average price target of $7.4998, representing an $563.70% surge from its current level. The forecast ranges from a conservative $5.2621 to a sky-high $6.0268.
- Our analysts predict FibroGen Inc (FGEN) to jump 2,835% by 2045, soaring from $35.12 to an average price of $33.17, potentially reaching $36.25. While $35.12 is the low estimate, the potential upside is significant.
- FibroGen Inc (FGEN) stock is expected to climb by 2050, reaching an average of $65.20, a $5,670% jump from its current level. However, a wide range of estimates exists, with high and low targets of $65.93 and $66.40, respectively, highlighting the market's uncertainty.
FibroGen Inc Stock (FGEN) Year by Year Forecast
FibroGen Inc Stock (FGEN) Price Forecast for 2024
Our forecast for FGEN stock price in 2024 now indicates an average price target of $8.5766 with a high forecast of $17.07 and a low forecast of $0.0841. The average prediction reflects an increase of +658.99% from the last recorded price of $1.13.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $11.05 | $1.9464 | $11.73 | +877.77% |
| July, 2024 | $14.30 | $8.457 | $15.23 | +1,165% |
| August, 2024 | $8.8458 | $8.7658 | $15.42 | +682.81% |
| September, 2024 | $7.3022 | $7.1122 | $13.63 | +546.21% |
| October, 2024 | $7.1627 | $2.5745 | $8.9463 | +533.87% |
| November, 2024 | $9.4092 | $2.1382 | $17.07 | +732.67% |
| December, 2024 | $16.43 | $1.0775 | $16.65 | +1,354% |
FibroGen Inc Stock (FGEN) Price Forecast for 2025
FibroGen Inc Stock (FGEN) is expected to reach an average price of $13.18 in 2025, with a high prediction of $25.67 and a low estimate of $0.7026. This indicates an +1,067% rise from the last recorded price of $1.13.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $12.87 | $12.32 | $18.15 | +1,039% |
| February, 2025 | $12.10 | $10.51 | $15.21 | +971.03% |
| March, 2025 | $11.36 | $9.4394 | $17.00 | +905.22% |
| April, 2025 | $5.1946 | $0.7026 | $13.56 | +359.70% |
| May, 2025 | $10.26 | $2.9037 | $12.46 | +807.61% |
| June, 2025 | $8.1425 | $5.1483 | $12.96 | +620.57% |
| July, 2025 | $12.39 | $4.6289 | $13.77 | +996.73% |
| August, 2025 | $14.85 | $11.96 | $17.31 | +1,214% |
| September, 2025 | $17.74 | $13.44 | $21.54 | +1,470% |
| October, 2025 | $17.29 | $13.79 | $25.67 | +1,430% |
| November, 2025 | $15.68 | $15.50 | $20.31 | +1,288% |
| December, 2025 | $13.51 | $12.63 | $24.61 | +1,096% |
FibroGen Inc Stock (FGEN) Price Forecast for 2026
The predicted value for FibroGen Inc (FGEN) in 2026 is set at an average of $17.19. Estimates vary from a peak of $34.17 to a trough of $0.2131, indicating an +1,421% surge from the present price of $1.13.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $15.76 | $12.94 | $19.93 | +1,295% |
| February, 2026 | $19.93 | $15.19 | $21.69 | +1,663% |
| March, 2026 | $19.73 | $13.13 | $20.86 | +1,646% |
| April, 2026 | $29.13 | $19.55 | $34.17 | +2,478% |
| May, 2026 | $11.65 | $9.5497 | $31.44 | +930.95% |
| June, 2026 | $3.4438 | $3.8938 | $14.05 | +204.77% |
| July, 2026 | $0.1167 | $0.4615 | $1.6885 | -89.67% |
| August, 2026 | $5.0731 | $0.2131 | $5.1021 | +348.95% |
| September, 2026 | $6.0537 | $3.7682 | $9.3663 | +435.72% |
| October, 2026 | $6.2399 | $6.9799 | $7.2478 | +452.20% |
| November, 2026 | $7.8734 | $7.7258 | $7.4234 | +596.76% |
| December, 2026 | $8.7129 | $7.6593 | $7.9829 | +671.05% |
FibroGen Inc Stock (FGEN) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for FibroGen Inc (FGEN) is $4.3648, with a high forecast of $8.4188 and a low forecast of $0.3108. This indicates an +286.26% increase from the last price of $1.13.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $7.6165 | $8.1865 | $8.4188 | +574.02% |
| February, 2027 | $5.81 | $6.1261 | $7.0523 | +414.16% |
| March, 2027 | $2.6795 | $4.4636 | $5.2218 | +137.12% |
| April, 2027 | $2.653 | $3.1813 | $2.493 | +134.78% |
| May, 2027 | $1.8566 | $2.3566 | $2.6889 | +64.30% |
| June, 2027 | $2.986 | $1.7084 | $2.066 | +164.25% |
| July, 2027 | $3.4896 | $3.1587 | $2.5396 | +208.81% |
| August, 2027 | $4.7932 | $3.2814 | $3.1032 | +324.17% |
| September, 2027 | $4.4326 | $5.6791 | $4.995 | +292.27% |
| October, 2027 | $4.0962 | $4.8203 | $4.3185 | +262.49% |
| November, 2027 | $1.2397 | $2.5697 | $2.1339 | +9.71% |
| December, 2027 | $1.4908 | $0.3108 | $1.6508 | +31.93% |
FibroGen Inc Stock (FGEN) Price Forecast for 2028
In 2028, FibroGen Inc (FGEN) is projected to reach an average price of $8.0652, with a high projection of $16.10 and a low estimate of $0.0263. This indicates an +613.73% rise from the last price of $1.13.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.0572 | $0.269 | $1.8849 | -94.93% |
| February, 2028 | $0.9237 | $0.0263 | $1.4637 | -18.26% |
| March, 2028 | $4.7642 | $0.7978 | $6.6801 | +321.61% |
| April, 2028 | $2.7907 | $1.9325 | $6.0833 | +146.96% |
| May, 2028 | $5.1212 | $2.8248 | $6.173 | +353.20% |
| June, 2028 | $9.9476 | $4.8053 | $11.15 | +780.32% |
| July, 2028 | $14.64 | $9.3718 | $16.10 | +1,196% |
| August, 2028 | $11.11 | $10.66 | $15.26 | +883.60% |
| September, 2028 | $11.04 | $9.2628 | $11.85 | +877.09% |
| October, 2028 | $9.3175 | $7.6834 | $12.58 | +724.56% |
| November, 2028 | $10.36 | $8.2616 | $11.62 | +816.64% |
| December, 2028 | $4.3655 | $4.6755 | $12.06 | +286.33% |
FibroGen Inc Stock (FGEN) Price Forecast for 2029
The 2029 price forecast for FibroGen Inc Stock (FGEN) is $10.13 on average, with a high prediction of $20.17 and a low estimate of $0.094. This represents an +796.64% increase from the previous price of $1.13.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $4.435 | $4.2914 | $4.4591 | +292.47% |
| February, 2029 | $4.8285 | $4.5309 | $4.7526 | +327.30% |
| March, 2029 | $4.719 | $4.772 | $4.7253 | +317.61% |
| April, 2029 | $4.5306 | $4.5356 | $4.5481 | +300.94% |
| May, 2029 | $4.175 | $4.1591 | $4.3465 | +269.47% |
| June, 2029 | $3.4703 | $3.5487 | $3.866 | +207.10% |
| July, 2029 | $2.7559 | $2.8988 | $3.2999 | +143.89% |
| August, 2029 | $1.1517 | $2.1906 | $2.6102 | +1.92% |
| September, 2029 | $0.7952 | $0.7593 | $0.4676 | -29.62% |
| October, 2029 | $0.5353 | $0.094 | $0.6153 | -52.63% |
| November, 2029 | $0.4383 | $0.3694 | $0.8694 | -61.22% |
| December, 2029 | $33.51 | $0.1559 | $20.17 | +2,865% |
FibroGen Inc Stock (FGEN) Price Forecast for 2030
FibroGen Inc Stock (FGEN) is expected to reach an average price of $23.66 in 2030, with a high forecast of $32.28 and a low forecast of $15.04. This signifies an +1,994% surge from the last price of $1.13.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $27.42 | $29.46 | $32.28 | +2,326% |
| February, 2030 | $21.65 | $23.82 | $22.66 | +1,816% |
| March, 2030 | $20.06 | $19.89 | $19.21 | +1,676% |
| April, 2030 | $21.10 | $21.64 | $20.00 | +1,767% |
| May, 2030 | $27.20 | $24.52 | $26.18 | +2,307% |
| June, 2030 | $23.91 | $24.71 | $26.05 | +2,016% |
| July, 2030 | $23.83 | $24.23 | $23.58 | +2,008% |
| August, 2030 | $15.75 | $15.04 | $17.86 | +1,294% |
| September, 2030 | $18.39 | $16.43 | $16.97 | +1,527% |
| October, 2030 | $13.56 | $15.75 | $17.22 | +1,100% |
| November, 2030 | $27.71 | $15.27 | $20.13 | +2,352% |
| December, 2030 | $25.48 | $25.84 | $28.40 | +2,155% |
0.52%
3.69%
Cap:
|
Volume (24h):